CEO of Xlear Nasal Spray Responds to U.S. DOJ Lawsuit Alleging FTC Violation
finance.yahoo.com
finance.yahoo.com
Earlier this year, March 2021, https://www.businesswire.com/news/home/20210324005241/en/Xle...
> Xlear previously filed a pre-EUA seeking approval for use of the nasal spray as a medical device in combatting COVID-19. However, because the FDA determined that Xlear “works against the virus,” the FDA told Xlear it would need to be considered as a drug or combination product EUA. Xlear is currently sold in over 50,000 pharmacies, grocery stores, and online as a nasal spray. “Xlear doesn’t require the EUA to be sold and used—we only need an EUA to be able to inform people about the benefits of using Xlear to protect themselves from COVID-19".